
Trump’s Chance at the UN
By THE NEW YORK SUN
|The most rigorous academic analysis to date of the research backing puberty blockers and cross-sex hormones as treatments for gender-related distress in young people has found it has produced ‘very uncertain’ evidence.

A pair of major new analyses of research into providing gender-transition drugs to adolescents and young adults have indicated that a prevailing orthodoxy in the American medical community — that such treatments are safe and effective for gender-distressed minors — is largely based on “very uncertain” scientific evidence.

By THE NEW YORK SUN
|
By MATTHEW RICE
|
By MATTHEW RICE
|
By LUKE FUNK
|
By VERONIQUE de RUGY
|
By JENNIFER DOHERTY
|
By LAURENCE ELDER
|
By LAWRENCE KUDLOW
|A pair of major new analyses of research into providing gender-transition drugs to adolescents and young adults have indicated that a prevailing orthodoxy in the American medical community — that such treatments are safe and effective for gender-distressed minors — is largely based on “very uncertain” scientific evidence.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime